Nevro Corp. (NVRO) Financials
Stock symbol NVRO is outdated, potentially delisted? Maybe it is available on other exchange?
NVRO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 553.8 million | 322.8 million |
| Sept. 30, 2024 | 595.6 million | 322.0 million |
| June 30, 2024 | 603.3 million | 329.1 million |
| March 31, 2024 | 596.1 million | 317.5 million |
NVRO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | 16.6 million | 12.5 million |
| Sept. 30, 2024 | 161000 | 11.4 million |
| June 30, 2024 | -10.5 million | 14.4 million |
| March 31, 2024 | -35.7 million | 12.8 million |
NVRO Net Income
No data available :(
NVRO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 292.5 million | 213.2 million | 25.5 million |
| Sept. 30, 2024 | 277.0 million | 208.7 million | 24.3 million |
| June 30, 2024 | 273.7 million | 204.4 million | 24.3 million |
| March 31, 2024 | 281.5 million | 217.9 million | 9.0 million |
NVRO Shares Outstanding
NVRO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | 2.0 million | 12.0 million | 76.2 million | - |
| Sept. 30, 2024 | 2.6 million | 10.6 million | 68.5 million | - |
| June 30, 2024 | 2.4 million | 14.1 million | 76.8 million | - |
| March 31, 2024 | 2.8 million | 14.8 million | 85.1 million | - |
NVRO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | 105.5 million | 39.6 million |
| Sept. 30, 2024 | 96.9 million | 32.3 million |
| June 30, 2024 | 104.2 million | 36.7 million |
| March 31, 2024 | 101.9 million | 34.3 million |
NVRO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
NVRO
Price: $5.84
52 week price:
Earnings Per Share: -3.06 USD
P/E Ratio: -1.91
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 496000
Ebitda: -2.7 millionMarket Capitalization: 224.1 million